Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.idc.2021.03.008 http://scihub22266oqcxt.onion/10.1016/j.idc.2021.03.008 34016284!ä!34016284 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34016284&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Infect+Dis+Clin+North+Am 2021 ; 35 (2): 415-434 Nephropedia Template TP {{tp|p=34016284|t=2021. Aspergillosis: Epidemiology, Diagnosis, and Treatment |pdf=|usr=}}{{34016284}} gab.com Text Aspergillosis: Epidemiology, Diagnosis, and Treatment JO: Infect Dis Clin North Am http://www.kidney.de/pget.php?&tw=1&pmid=34016284 #FOAvip The spectrum of disease produced by Aspergillus species ranges from allergic syndromes to chronic pulmonary conditions and invasive infections. Invasive aspergillosis is a major cause of morbidity and mortality in immunocompromised patients. Risk factors continue to evolve and include newer biological agents that target the immune system and postinfluenza infection; and it has been observed following COVID-19 infection. Diagnosis remains a challenge but non-culture-based methods are available. Antifungal resistance has emerged. Voriconazole remains the treatment of choice but isavuconazole and posaconazole have similar efficacy with less toxicity. Combination therapy is used with extensive infection and in severe immunosuppression. Twit Text FOAVip Aspergillosis: Epidemiology, Diagnosis, and Treatment ????Infect Dis Clin North Am http://www.kidney.de/pget.php?&tw=1&pmid=34016284 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34016284 #FOAvip English Wikipedia <ref>{{Cite pmid|34016284}}</ref> Aspergillosis: Epidemiology, Diagnosis, and Treatment #MMPMID34016284 Cadena J; Thompson GR 3rd; Patterson TF Infect Dis Clin North Am 2021[Jun]; 35 (2): 415-434 PMID34016284show ga The spectrum of disease produced by Aspergillus species ranges from allergic syndromes to chronic pulmonary conditions and invasive infections. Invasive aspergillosis is a major cause of morbidity and mortality in immunocompromised patients. Risk factors continue to evolve and include newer biological agents that target the immune system and postinfluenza infection; and it has been observed following COVID-19 infection. Diagnosis remains a challenge but non-culture-based methods are available. Antifungal resistance has emerged. Voriconazole remains the treatment of choice but isavuconazole and posaconazole have similar efficacy with less toxicity. Combination therapy is used with extensive infection and in severe immunosuppression. |*Aspergillosis/complications/diagnosis/drug therapy/epidemiology[MESH] |Antifungal Agents/*therapeutic use[MESH] |Aspergillus/classification/isolation & purification[MESH] |COVID-19/complications[MESH] |Disease Susceptibility[MESH] |Drug Resistance, Fungal[MESH] |Humans[MESH] |Immunocompromised Host[MESH] |Invasive Pulmonary Aspergillosis/diagnosis/drug therapy/epidemiology[MESH]Aspergillosis: Epidemiology, Diagnosis, and Treatment (epmc).pdf DeepDyve Pubget Overpricing